Skip to main content

Find Clinical Trials

Home
Conditions
Prostatic Neoplasms

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,742 public trials 967 recruiting studies

Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA

NCT00148928

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Brussels, Belgium

GSK Investigational Site Turnhout, Belgium

GSK Investigational Site Auxerre, France

View Trial Details

Completed

Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer

NCT00375648

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations: Novartis Investigative Site Monpellier, France

View Trial Details

Completed

PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer

NCT00898326

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Jikei University School of Medicine Hospital Tokyo, Japan

View Trial Details

Completed

Sulphate Accumulation in Prostate

NCT02821728

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Institute of Food Research Norwich, Norfolk, United Kingdom

View Trial Details

Completed

Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

NCT01316458

Conditions: Abdominal Neoplasms, Antineoplastic Agents, Female Urogenital Diseases, +14 more
Locations: Novartis Investigative Site Aachen, Germany

Novarts Investigative Site Berlin, Germany

Novartis Investigative Site Bonn, Germany

Novartis Investigative Site Borken, Germany

View all 13 locations

View Trial Details

Completed

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

NCT00225420

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

Rex Cancer Center at Rex Hospital Raleigh, North Carolina, United States

View Trial Details

Completed

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

NCT00219271

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Novartis Investigative Site Athens, Greece

View Trial Details

Completed

Economic Analyses of the REDUCE Trial

NCT01337258

Conditions: Benign Prostatic Hyperplasia, Cancer, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

NCT01431391

Conditions: Adenocarcinoma, Carcinoma, Female Urogenital Diseases, +16 more
Locations: Urology Center of Alabama Homewood, Alabama, United States

University of California San Diego / Moores Cancer Center La Jolla, California, United States

Keck Hospital of USC Los Angeles, California, United States

LAC + USC Medical Center Los Angeles, California, United States

View all 14 locations

View Trial Details

Completed

Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss

NCT00925600

Conditions: Bone Diseases, Bone Diseases, Metabolic, Cancer, +20 more
Locations: Research Site Anaheim, California, United States

Research Site Laguna Hills, California, United States

Research Site Murrieta, California, United States

Research Site San Diego, California, United States

View all 172 locations

View Trial Details